Patents by Inventor Kerstin Rebrin

Kerstin Rebrin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220047194
    Abstract: Method and device for outputting one or more signals associated with a monitored analyte level of an individual, the one or more signals including a substantially real time monitored analyte level and a rate of change information associated with the monitored analyte level, outputting a carbohydrate intake event indication, determining one or more data associated with one or more therapy information related to the monitored analyte level and the meal event indication, and outputting the determined one or more data over the outputted one or more signals associated with the monitored analyte level and the carbohydrate intake event indication are provided.
    Type: Application
    Filed: November 1, 2021
    Publication date: February 17, 2022
    Inventors: Thomas A. PEYSER, Marc B. TAUB, R. Curtis JENNEWINE, Timothy Christian DUNN, Kerstin REBRIN
  • Patent number: 11166654
    Abstract: Method and device for outputting one or more signals associated with a monitored analyte level of an individual, the one or more signals including a substantially real time monitored analyte level and a rate of change information associated with the monitored analyte level, outputting a carbohydrate intake event indication, determining one or more data associated with one or more therapy information related to the monitored analyte level and the meal event indication, and outputting the determined one or more data over the outputted one or more signals associated with the monitored analyte level and the carbohydrate intake event indication are provided.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: November 9, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Thomas A. Peyser, Marc B. Taub, R. Curtis Jennewine, Timothy Christian Dunn, Kerstin Rebrin
  • Publication number: 20190008433
    Abstract: Method and device for outputting one or more signals associated with a monitored analyte level of an individual, the one or more signals including a substantially real time monitored analyte level and a rate of change information associated with the monitored analyte level, outputting a carbohydrate intake event indication, determining one or more data associated with one or more therapy information related to the monitored analyte level and the meal event indication, and outputting the determined one or more data over the outputted one or more signals associated with the monitored analyte level and the carbohydrate intake event indication are provided.
    Type: Application
    Filed: August 30, 2018
    Publication date: January 10, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Thomas A. Peyser, Marc B. Taub, R. Curtis Jennewine, Timothy Christian Dunn, Kerstin Rebrin
  • Patent number: 10080529
    Abstract: Apparatuses and methods for medical monitoring physiological characteristics values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide dynamic glucose monitoring functions that perform predictive analysis to anticipate harmful conditions, such as glucose crash and hyperglycemic incidents for a patient. The dynamic functions can also be used to maximize athletic performance and warn of inadequate nocturnal basal rate. Other aspects include advanced alarm and reminder functions, as well as advanced data presentation tools to further facilitate convenient and efficient management of various physiological conditions.
    Type: Grant
    Filed: January 16, 2015
    Date of Patent: September 25, 2018
    Assignee: Medtronic MiniMed, Inc.
    Inventors: James Kelly Fox, Garry M. Steil, Kerstin Rebrin, Mark C. Estes, Frank Saidara
  • Publication number: 20150374271
    Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.
    Type: Application
    Filed: September 4, 2015
    Publication date: December 31, 2015
    Inventors: Geoffrey V. McGarraugh, Benjamin J. Feldman, Thomas A. Peyser, John C. Mazza, Timothy T. Goodnow, Kerstin Rebrin
  • Publication number: 20150190100
    Abstract: Apparatuses and methods for medical monitoring physiological characteristics values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide dynamic glucose monitoring functions that perform predictive analysis to anticipate harmful conditions, such as glucose crash and hyperglycemic incidents for a patient. The dynamic functions can also be used to maximize athletic performance and warn of inadequate nocturnal basal rate. Other aspects include advanced alarm and reminder functions, as well as advanced data presentation tools to further facilitate convenient and efficient management of various physiological conditions.
    Type: Application
    Filed: January 16, 2015
    Publication date: July 9, 2015
    Inventors: James Kelly Fox, Garry M. Steil, Kerstin Rebrin, Mark C. Estes, Frank Saidara
  • Patent number: 7920907
    Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.
    Type: Grant
    Filed: June 7, 2007
    Date of Patent: April 5, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Geoffrey V. McGarraugh, Benjamin J. Feldman, Thomas A. Peyser, John C. Mazza, Timothy T. Goodnow, Kerstin Rebrin
  • Patent number: 7766830
    Abstract: Apparatuses and methods for medical monitoring physiological characteristics values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide dynamic glucose monitoring functions that perform predictive analysis to anticipate harmful conditions, such as glucose crash and hyperglycemic incidents for a patient. The dynamic functions can also be used to maximize athletic performance and warn of inadequate nocturnal basal rate. Other aspects include advanced alarm and reminder functions, as well as advanced data presentation tools to further facilitate convenient and efficient management of various physiological conditions.
    Type: Grant
    Filed: November 30, 2004
    Date of Patent: August 3, 2010
    Assignee: Medtronic MiniMed, Inc.
    Inventors: James Kelly Fox, Garry M. Steil, Kerstin Rebrin, Mark C. Estes, Frank Saidara
  • Publication number: 20090281406
    Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.
    Type: Application
    Filed: July 20, 2009
    Publication date: November 12, 2009
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Geoffrey V. McGarraugh, Benjamin J. Feldman, Thomas A. Peyser, John C. Mazza, Timothy T. Goodnow, Kerstin Rebrin
  • Publication number: 20090143725
    Abstract: Method and device for outputting one or more signals associated with a monitored analyte level of an individual, the one or more signals including a substantially real time monitored analyte level and a rate of change information associated with the monitored analyte level, outputting a carbohydrate intake event indication, determining one or more data associated with one or more therapy information related to the monitored analyte level and the meal event indication, and outputting the determined one or more data over the outputted one or more signals associated with the monitored analyte level and the carbohydrate intake event indication are provided.
    Type: Application
    Filed: August 28, 2008
    Publication date: June 4, 2009
    Applicant: Abbott Diabetes Care, Inc.
    Inventors: Thomas A. Peyser, Marc B. Taub, R. Curtis Jennewine, Timothy Christian Dunn, Kerstin Rebrin
  • Publication number: 20080188796
    Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.
    Type: Application
    Filed: April 4, 2008
    Publication date: August 7, 2008
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Garry M. Steil, Kerstin Rebrin
  • Patent number: 7402153
    Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: July 22, 2008
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Garry M. Steil, Kerstin Rebrin
  • Patent number: 7354420
    Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.
    Type: Grant
    Filed: May 3, 2006
    Date of Patent: April 8, 2008
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Garry M. Steil, Kerstin Rebrin
  • Publication number: 20080071157
    Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.
    Type: Application
    Filed: June 7, 2007
    Publication date: March 20, 2008
    Applicant: Abbott Diabetes Care, Inc.
    Inventors: Geoffrey McGarraugh, Benjamin Feldman, Thomas Peyser, John Mazza, Timothy Goodnow, Kerstin Rebrin
  • Publication number: 20080071158
    Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.
    Type: Application
    Filed: June 7, 2007
    Publication date: March 20, 2008
    Applicant: Abbott Diabetes Care, Inc.
    Inventors: Geoffrey McGarraugh, Benjamin Feldman, Thomas Peyser, John Mazza, Timothy Goodnow, Kerstin Rebrin
  • Publication number: 20080064937
    Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.
    Type: Application
    Filed: June 7, 2007
    Publication date: March 13, 2008
    Applicant: Abbott Diabetes Care, Inc.
    Inventors: Geoffrey McGarraugh, Benjamin Feldman, Thomas Peyser, John Mazza, Timothy Goodnow, Kerstin Rebrin
  • Publication number: 20080058625
    Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.
    Type: Application
    Filed: June 7, 2007
    Publication date: March 6, 2008
    Applicant: Abbott Diabetes Care, Inc.
    Inventors: Geoffrey McGarraugh, Benjamin Feldman, Thomas Peyser, John Mazza, Timothy Goodnow, Kerstin Rebrin
  • Patent number: 7267665
    Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.
    Type: Grant
    Filed: December 31, 2002
    Date of Patent: September 11, 2007
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Garry M. Steil, Kerstin Rebrin
  • Publication number: 20060224109
    Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.
    Type: Application
    Filed: May 3, 2006
    Publication date: October 5, 2006
    Inventors: Garry Steil, Kerstin Rebrin
  • Patent number: 7022072
    Abstract: Apparatuses and methods for medical monitoring physiological characteristics values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide dynamic glucose monitoring functions that perform predictive analysis to anticipate harmful conditions, such as glucose crash and hyperglycemic incidents for a patient. The dynamic functions can also be used to maximize athletic performance and warn of inadequate nocturnal basal rate. Other aspects include advanced alarm and reminder functions, as well as advanced data presentation tools to further facilitate convenient and efficient management of various physiological conditions.
    Type: Grant
    Filed: December 27, 2001
    Date of Patent: April 4, 2006
    Assignee: Medtronic MiniMed, Inc.
    Inventors: James Kelly Fox, Garry M. Steil, Kerstin Rebrin, Mark C. Estes, Frank Saidara